Taking into consideration these molecular pathways, the possible involvement of gut‐liver axis through the PAMPs/TLR‐4/pro‐inflammatory cytokines axis in the pathogenesis of inflammatory processes during NASH and ASH seems obvious. The gene discussed is TLR4; the disease is metabolic dysfunction-associated steatohepatitis.